Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.
Identifieur interne : 000C47 ( Main/Corpus ); précédent : 000C46; suivant : 000C48Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.
Auteurs : Donna Papsun ; Alison Krywanczyk ; James C. Vose ; Elizabeth A. Bundock ; Barry K. LoganSource :
- Journal of analytical toxicology [ 1945-2403 ] ; 2016.
English descriptors
- KwdEn :
- Adult (MeSH), Analgesics, Opioid (blood), Analgesics, Opioid (poisoning), Chromatography, High Pressure Liquid (MeSH), Designer Drugs (poisoning), Diazepam (analogs & derivatives), Diazepam (poisoning), Fatal Outcome (MeSH), Humans (MeSH), Male (MeSH), Piperazines (blood), Piperazines (poisoning), Reproducibility of Results (MeSH), Tandem Mass Spectrometry (MeSH).
- MESH :
- chemical , analogs & derivatives : Diazepam.
- chemical , blood : Analgesics, Opioid, Piperazines.
- chemical , poisoning : Analgesics, Opioid, Designer Drugs, Diazepam, Piperazines.
- Adult, Chromatography, High Pressure Liquid, Fatal Outcome, Humans, Male, Reproducibility of Results, Tandem Mass Spectrometry.
Abstract
MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) is just one of the many novel psychoactive substances (NPS) to have reached the recreational drug market in the twenty-first century; it is however, one of the first designer opioids to achieve some degree of popularity, in a market currently dominated by synthetic cannabinoids and designer stimulants. A single fatality involving MT-45 and etizolam is described. A method for the quantitation of MT-45 in whole blood using liquid chromatography-tandem mass spectrometry was developed and validated. The linear range was determined to be 1.0-100 ng/mL with a detection limit of 1.0 ng/mL, and the method met the requirements for acceptable linearity, precision and accuracy. After analyzing the sample on dilution and by standard addition, the concentration of MT-45 in the decedent's blood was determined to be 520 ng/mL, consistent with other concentrations of MT-45 reported in drug-related fatalities. Etizolam was present at a concentration of 35 ng/mL. This case illustrates the importance of considering non-traditional drugs in unexplained apparent drug-related deaths.
DOI: 10.1093/jat/bkw012
PubMed: 27091064
Links to Exploration step
pubmed:27091064Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.</title>
<author><name sortKey="Papsun, Donna" sort="Papsun, Donna" uniqKey="Papsun D" first="Donna" last="Papsun">Donna Papsun</name>
<affiliation><nlm:affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krywanczyk, Alison" sort="Krywanczyk, Alison" uniqKey="Krywanczyk A" first="Alison" last="Krywanczyk">Alison Krywanczyk</name>
<affiliation><nlm:affiliation>Department of Pathology, University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vose, James C" sort="Vose, James C" uniqKey="Vose J" first="James C" last="Vose">James C. Vose</name>
<affiliation><nlm:affiliation>Vermont Forensic Laboratory, P.O. Box 47, Waterbury, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bundock, Elizabeth A" sort="Bundock, Elizabeth A" uniqKey="Bundock E" first="Elizabeth A" last="Bundock">Elizabeth A. Bundock</name>
<affiliation><nlm:affiliation>Office of the Chief Medical Examiner, 111 Colchester Avenue, Burlington, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Logan, Barry K" sort="Logan, Barry K" uniqKey="Logan B" first="Barry K" last="Logan">Barry K. Logan</name>
<affiliation><nlm:affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA The Center for Forensic Science Research and Education (CFSRE), 2300 Welsh Rd, Willow Grove, PA, USA barry.logan@nmslabs.com.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:27091064</idno>
<idno type="pmid">27091064</idno>
<idno type="doi">10.1093/jat/bkw012</idno>
<idno type="wicri:Area/Main/Corpus">000C47</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C47</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.</title>
<author><name sortKey="Papsun, Donna" sort="Papsun, Donna" uniqKey="Papsun D" first="Donna" last="Papsun">Donna Papsun</name>
<affiliation><nlm:affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Krywanczyk, Alison" sort="Krywanczyk, Alison" uniqKey="Krywanczyk A" first="Alison" last="Krywanczyk">Alison Krywanczyk</name>
<affiliation><nlm:affiliation>Department of Pathology, University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Vose, James C" sort="Vose, James C" uniqKey="Vose J" first="James C" last="Vose">James C. Vose</name>
<affiliation><nlm:affiliation>Vermont Forensic Laboratory, P.O. Box 47, Waterbury, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bundock, Elizabeth A" sort="Bundock, Elizabeth A" uniqKey="Bundock E" first="Elizabeth A" last="Bundock">Elizabeth A. Bundock</name>
<affiliation><nlm:affiliation>Office of the Chief Medical Examiner, 111 Colchester Avenue, Burlington, VT, USA.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Logan, Barry K" sort="Logan, Barry K" uniqKey="Logan B" first="Barry K" last="Logan">Barry K. Logan</name>
<affiliation><nlm:affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA The Center for Forensic Science Research and Education (CFSRE), 2300 Welsh Rd, Willow Grove, PA, USA barry.logan@nmslabs.com.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Journal of analytical toxicology</title>
<idno type="eISSN">1945-2403</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult (MeSH)</term>
<term>Analgesics, Opioid (blood)</term>
<term>Analgesics, Opioid (poisoning)</term>
<term>Chromatography, High Pressure Liquid (MeSH)</term>
<term>Designer Drugs (poisoning)</term>
<term>Diazepam (analogs & derivatives)</term>
<term>Diazepam (poisoning)</term>
<term>Fatal Outcome (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Piperazines (blood)</term>
<term>Piperazines (poisoning)</term>
<term>Reproducibility of Results (MeSH)</term>
<term>Tandem Mass Spectrometry (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en"><term>Diazepam</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Piperazines</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="poisoning" xml:lang="en"><term>Analgesics, Opioid</term>
<term>Designer Drugs</term>
<term>Diazepam</term>
<term>Piperazines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Chromatography, High Pressure Liquid</term>
<term>Fatal Outcome</term>
<term>Humans</term>
<term>Male</term>
<term>Reproducibility of Results</term>
<term>Tandem Mass Spectrometry</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) is just one of the many novel psychoactive substances (NPS) to have reached the recreational drug market in the twenty-first century; it is however, one of the first designer opioids to achieve some degree of popularity, in a market currently dominated by synthetic cannabinoids and designer stimulants. A single fatality involving MT-45 and etizolam is described. A method for the quantitation of MT-45 in whole blood using liquid chromatography-tandem mass spectrometry was developed and validated. The linear range was determined to be 1.0-100 ng/mL with a detection limit of 1.0 ng/mL, and the method met the requirements for acceptable linearity, precision and accuracy. After analyzing the sample on dilution and by standard addition, the concentration of MT-45 in the decedent's blood was determined to be 520 ng/mL, consistent with other concentrations of MT-45 reported in drug-related fatalities. Etizolam was present at a concentration of 35 ng/mL. This case illustrates the importance of considering non-traditional drugs in unexplained apparent drug-related deaths. </div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">27091064</PMID>
<DateCompleted><Year>2017</Year>
<Month>01</Month>
<Day>19</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>01</Month>
<Day>19</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-2403</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>40</Volume>
<Issue>4</Issue>
<PubDate><Year>2016</Year>
<Month>May</Month>
</PubDate>
</JournalIssue>
<Title>Journal of analytical toxicology</Title>
<ISOAbbreviation>J Anal Toxicol</ISOAbbreviation>
</Journal>
<ArticleTitle>Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death.</ArticleTitle>
<Pagination><MedlinePgn>313-7</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1093/jat/bkw012</ELocationID>
<Abstract><AbstractText>MT-45 (1-cyclohexyl-4-(1,2-diphenylethyl)piperazine) is just one of the many novel psychoactive substances (NPS) to have reached the recreational drug market in the twenty-first century; it is however, one of the first designer opioids to achieve some degree of popularity, in a market currently dominated by synthetic cannabinoids and designer stimulants. A single fatality involving MT-45 and etizolam is described. A method for the quantitation of MT-45 in whole blood using liquid chromatography-tandem mass spectrometry was developed and validated. The linear range was determined to be 1.0-100 ng/mL with a detection limit of 1.0 ng/mL, and the method met the requirements for acceptable linearity, precision and accuracy. After analyzing the sample on dilution and by standard addition, the concentration of MT-45 in the decedent's blood was determined to be 520 ng/mL, consistent with other concentrations of MT-45 reported in drug-related fatalities. Etizolam was present at a concentration of 35 ng/mL. This case illustrates the importance of considering non-traditional drugs in unexplained apparent drug-related deaths. </AbstractText>
<CopyrightInformation>© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Papsun</LastName>
<ForeName>Donna</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Krywanczyk</LastName>
<ForeName>Alison</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Pathology, University of Vermont College of Medicine, 89 Beaumont Avenue, Burlington, VT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Vose</LastName>
<ForeName>James C</ForeName>
<Initials>JC</Initials>
<AffiliationInfo><Affiliation>Vermont Forensic Laboratory, P.O. Box 47, Waterbury, VT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bundock</LastName>
<ForeName>Elizabeth A</ForeName>
<Initials>EA</Initials>
<AffiliationInfo><Affiliation>Office of the Chief Medical Examiner, 111 Colchester Avenue, Burlington, VT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Logan</LastName>
<ForeName>Barry K</ForeName>
<Initials>BK</Initials>
<AffiliationInfo><Affiliation>NMS Labs, 2300 Welsh Rd, Willow Grove, PA, USA The Center for Forensic Science Research and Education (CFSRE), 2300 Welsh Rd, Willow Grove, PA, USA barry.logan@nmslabs.com.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>J Anal Toxicol</MedlineTA>
<NlmUniqueID>7705085</NlmUniqueID>
<ISSNLinking>0146-4760</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000701">Analgesics, Opioid</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015198">Designer Drugs</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D010879">Piperazines</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>52694-55-0</RegistryNumber>
<NameOfSubstance UI="C012631">(+,-)-1-cyclohexyl-4-(1,2-diphenylethyl)piperazine</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>A76XI0HL37</RegistryNumber>
<NameOfSubstance UI="C044610">etizolam</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>Q3JTX2Q7TU</RegistryNumber>
<NameOfSubstance UI="D003975">Diazepam</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000701" MajorTopicYN="N">Analgesics, Opioid</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002851" MajorTopicYN="N">Chromatography, High Pressure Liquid</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015198" MajorTopicYN="N">Designer Drugs</DescriptorName>
<QualifierName UI="Q000506" MajorTopicYN="N">poisoning</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003975" MajorTopicYN="N">Diazepam</DescriptorName>
<QualifierName UI="Q000031" MajorTopicYN="N">analogs & derivatives</QualifierName>
<QualifierName UI="Q000506" MajorTopicYN="N">poisoning</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017809" MajorTopicYN="N">Fatal Outcome</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010879" MajorTopicYN="N">Piperazines</DescriptorName>
<QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName>
<QualifierName UI="Q000506" MajorTopicYN="Y">poisoning</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D053719" MajorTopicYN="N">Tandem Mass Spectrometry</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>4</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2017</Year>
<Month>1</Month>
<Day>20</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">27091064</ArticleId>
<ArticleId IdType="pii">bkw012</ArticleId>
<ArticleId IdType="doi">10.1093/jat/bkw012</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C47 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000C47 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Bois |area= WillowV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:27091064 |texte= Analysis of MT-45, a Novel Synthetic Opioid, in Human Whole Blood by LC-MS-MS and its Identification in a Drug-Related Death. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:27091064" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a WillowV1
This area was generated with Dilib version V0.6.37. |